cupric sulfide has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, Z; Lao, X; Li, B; Wang, Y; Xie, D | 1 |
| Cai, W; Chen, F; Ehlerding, EB; Goel, S; Graves, SA; Hong, H; Nickles, RJ; Orbay, H; Shi, S; Theuer, CP | 1 |
2 other study(ies) available for cupric sulfide and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Cetuximab-modified CuS nanoparticles integrating near-infrared-II-responsive photothermal therapy and anti-vessel treatment.
Topics: Animals; Cell Death; Cell Line, Tumor; Cetuximab; Chickens; Copper; Endocytosis; Female; Fluorescence; Human Umbilical Vein Endothelial Cells; Humans; Hyperthermia, Induced; Infrared Rays; Mice, Nude; Nanoparticles; Neoplasms; Neovascularization, Pathologic; Phototherapy | 2018 |
In Vivo Tumor Vasculature Targeting of CuS@MSN Based Theranostic Nanomedicine.
Topics: Ablation Techniques; Animals; Antineoplastic Agents; Copper; Drug Carriers; Endoglin; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Intracellular Signaling Peptides and Proteins; Mammary Neoplasms, Experimental; Mice; Nanostructures; Neovascularization, Pathologic; Polyethylene Glycols; Porosity; Positron-Emission Tomography; Silicon Dioxide; Theranostic Nanomedicine; Tissue Distribution | 2015 |